Sun's generic of anticoagulant Plavix receives FDA approval

07/31/2011 | Business Standard (India)

The FDA is allowing Sun Pharmaceutical Industries to launch a 75-milligram dose of clopidogrel USP, a generic version of Sanofi and Bristol-Myers Squibb's anticoagulant Plavix. The tablet is given to patients with "acute coronary syndrome, recent myocardial infarction ... recent stroke or established peripheral arterial disease," Sun said.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations